Synthesis of N1′-([11C]methyl)naltrindole ([11C]MeNTI): A radioligand for positron emission tomographic studies of delta opioid receptors
✍ Scribed by John R. Lever; Chris M. Kinter; Hayden T. Ravert; John L. Musachio; William B. Mathews; Robert F. Dannals
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- French
- Weight
- 508 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
A delta opioid receptor antagonist, N1′‐methylnaltrindole (MeNTI), has been labeled with carbon‐11. The precursor for radiolabeling was prepared in 71% yield by benzylation of the phenolic moiety of naltrindole. Alkylation of the indole nitrogen using [^11^C]iodomethane and aqueous tetra(n‐butyl)ammonium hydroxide at 80 °C in dimethylformamide followed by hydrogenolysis (H~2~, 10% Pd‐C) of the benzyl protecting group gave [^11^C]MeNTI. The average (n = 10) time for radiosynthesis, HPLC purification and formulation was 24 min from end‐of‐bombardment. [^11^C]MeNTI of high radiochemical purity was obtained at end‐of‐synthesis with an average specific activity of 2050 mCi/μmol and radiochemical yield, based on [^11^C]iodomethane, of 6%.
📜 SIMILAR VOLUMES
## Abstract Doxepin (3‐dibenz [b,e] oxepin ‐ 11(6H) ‐ ylidene ‐ N,N ‐ dimethyl ‐ 1 ‐ propanamine), a potent H~1~ histamine antagonist, was labeled with ^11^C‐iodomethane by N‐alkylation of normethyldoxepin. The synthesis, purification, and formulation were performed in approximately 20 minutes with
The novel 2-mercaptoimidazole derivatives, 1-[4-((2-methoxyphenyl)-1-piperazinyl)butyl]-2-mercaptoimidazole (3) and methyl[4-((2-methoxyphenyl)-1-piperazinyl))butyl] (2-mercapto-1-methylimidazol-5-yl)methanamide ( 8), were efficiently labelled with 11 C through methylation of the thioketone function